Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	43.13	55.86	39.03
Graham Fair Price	-3.05	828.16	854.24
PEG	276.72	-4.70	1.25
Price/Book	35.12	6.46	4.78
Price/Cash Flow	19.44	87.92	73.62
Prices/Earnings	58.70	26.04	16.41
Price/Sales	49.91	39.64	26.44
Price/FCF	19.44	87.92	73.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.06	0.53	0.53
Operating Margin	1.09	0.42	0.42
ROA	-14.46	0.04	0.05
ROE	0.07	0.06	-14.86
ROIC	0.05	0.05	-10.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.02	235.50
Dividends QOQ	0.09	< 0.005	-99.52
EBIT QOQ	0.14	-0.04	-70.08
EPS QOQ	0.13	-0.06	-57.87
FCF QOQ	2.30	0.19	-91.79
Revenue QOQ	0.14	-0.05	-63.52
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.90	86.44	12.40
Days Sales Outstanding (DSO)	29.06	30.69	5.57
Inventory Turnover	1.17	1.04	-11.03
Debt/Capitalization	0.21	0.21	0.25
Quick Ratio	2.07	2.07	0.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	667.27	701.07	5.07
Cash	325.59	370.76	13.87
Capex	-32.83	-35.36	-7.71
Free Cash Flow	43.34	51.52	18.86
Revenue	120.67	114.28	-5.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.40	2.39	-0.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.23	-1.69	-36.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating